Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Research context
Jiangsu Hengrui Medicine Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Jiangsu Hengrui Medicine Co., Ltd is currently in a long term downtrend where the price is trading 20.4% below its 200 day moving average.
From a valuation standpoint, the stock is 98.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 19.1.
Jiangsu Hengrui Medicine Co., Ltd's total revenue rose by 17.1% to $8B since the same quarter in the previous year.
Its net income has increased by 20.7% to $2B since the same quarter in the previous year.
Finally, its free cash flow fell by 61.2% to $382M since the same quarter in the previous year.
Based on the above factors, Jiangsu Hengrui Medicine Co., Ltd gets an overall score of 2/5.